Gene therapy for Parkinson’s disease using recombinant adeno-associated viral vectors

By Muramatsu Shin-ichi   Tsukada Hideo   Nakano Imaharu   Ozawa Keiya  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 5, 2005-05 ,pp. : 663-671

Informa Healthcare

Access to resources Recommend Favorite

Genetic analysis of the ATP1B4 gene in Chinese Han patients with Parkinson’s disease

By Gao Kai   Song Zhi   Liang Hui   Zheng Wen   Deng Xiong   Yuan Yi   Zhao Yongxiang   Deng Hao  

Molecular Biology Reports, Vol. 41, Iss. 4, 2014-04 ,pp. : 2307-2311

Springer Publishing Company

Access to resources Recommend Favorite

Proteomic approach to studying parkinson’s disease

By Zhang Jing   Goodlett David  

Molecular Neurobiology, Vol. 29, Iss. 3, 2004-06 ,pp. : 271-288

Humana Press, Inc

Access to resources Recommend Favorite

Environmental toxins and α-synuclein in Parkinson’s disease

By Liu Yanying   Yang Hui  

Molecular Neurobiology, Vol. 31, Iss. 1-3, 2005-02 ,pp. : 273-282

Humana Press, Inc

Access to resources Recommend Favorite

Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson’s disease

By Bonsi P.   Cuomo D.   Picconi B.   Sciamanna G.   Tscherter A.   Tolu M.   Bernardi G.   Calabresi P.   Pisani A.  

Amino Acids, Vol. 32, Iss. 2, 2007-02 ,pp. : 189-195

Springer Publishing Company

Access to resources Recommend Favorite